Patents by Inventor Jens Niewohner

Jens Niewohner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE THERMAL PRE-CONDITIONING OF A VEHICLE, SYSTEM, COMPUTER PROGRAM
    Publication number: 20230356563
    Abstract: A method for the thermal pre-conditioning of a vehicle having an electric drive unit and an electrical energy reservoir. The method includes at least the following step: the thermal pre-conditioning of a component of the vehicle while the electrical energy reservoir of the vehicle is connected to the external electrical energy supply.
    Type: Application
    Filed: May 4, 2023
    Publication date: November 9, 2023
    Applicant: Dr. Ing. h.c. F. Porsche Aktiengesellschaft
    Inventors: Manuel Groß, Christoph Siegmund Bara, Domenica Fresca, Jens Niewöhner, Patrick Böhl, Marcel Straub, Stefano Ruberto
  • MOTOR VEHICLE WITH A TRACTION BATTERY
    Publication number: 20230268577
    Abstract: A motor vehicle having a traction battery accommodated in a motor vehicle body. The traction battery is configured for an electric drive. A cooling system is provided for cooling the electric drive. An underbody element of an underbody of the vehicle body includes a passage opening, which can be opened or closed with the aid of a closing element. The underbody element is provided for the purpose of cooling the traction battery.
    Type: Application
    Filed: February 22, 2023
    Publication date: August 24, 2023
    Applicant: Dr. Ing. h.c. F. Porsche Aktiengesellschaft
    Inventors: Manuel Groß, Christoph Siegmund Bara, Domenica Fresca, Jens Niewöhner, Patrick Böhl, Marcel Straub, Stefano Ruberto
  • AXL antibodies
    Patent number: 8933202
    Abstract: The present invention refers to antibodies, particularly to monoclonal antibodies, which bind to the extracellular domain of the AXL receptor tyrosine kinase and which at least partially inhibit AXL activity.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: January 13, 2015
    Assignee: U3 Pharma GmbH
    Inventors: Thore Hettmann, Jens Niewöhner, Jens Ruhe, Peter Wirtz, Kerstin Selle, Esther Zwick-Wallasch, Mike Rothe
  • NEUROPILIN-1 INHIBITORS
    Publication number: 20120058117
    Abstract: The present invention relates to molecules interfering with the function of neuropilin-1 in the context of angiogenesis and the treatment of cancer. Molecules, polypeptides, antibodies, compositions and methods are provided that are useful for reducing, inhibiting or treating angiogenesis, the invasion of blood vessels into tumors, and/or the invasion or the metastatic potential of specific tumor cells. Additionally, a method is provided that allows identifying molecules, which interfere with the functionality of neuropilin-1. Furthermore, a method is provided that allows determining whether a naturally occurring tumor cell depends on functional neuropilin-1 for its invasiveness and/or metastatic potential.
    Type: Application
    Filed: June 22, 2011
    Publication date: March 8, 2012
    Applicants: MEDAREX, INC., TUFTS UNIVERSITY
    Inventors: Christine Margarete UNGER, Gerald BESTE, Carolin ZEHETMEIER, Blanca LAIN, Claudia TORELLA, Jens NIEWÖHNER, Daniel G. JAY, Brenda K. EUSTACE, Roland KNAUER, Kristian Hobold JENSEN
  • Neuropilin-1 inhibitors
    Publication number: 20060115477
    Abstract: The present invention relates to molecules interfering with the function of neuropilin-1 in the context of angiogenesis and the treatment of cancer. Molecules, polypeptides, antibodies, compositions and methods are provided that are useful for reducing, inhibiting or treating angiogenesis, the invasion of blood vessels into tumors, and/or the invasion or the metastatic potential of specific tumor cells. Additionally, a method is provided that allows identifying molecules, which interfere with the functionality of neuropilin-1. Furthermore, a method is provided that allows determining whether a naturally occuring tumor cell depends on functional neuropilin-1 for its invasiveness and/or metastatic potential.
    Type: Application
    Filed: December 22, 2003
    Publication date: June 1, 2006
    Inventors: Christine Unger, Gerald Beste, Carolin Zehetmeier, Blanca Lain, Claudia Torella, Jens Niewohner, Daniel Jay, Brenda Eustace, Roland Knauer, Kristian Jensen